PLUS THERAPEUTICS Inc. (NASDAQ: PSTV) Stock Information | RedChip

PLUS THERAPEUTICS Inc. (NASDAQ: PSTV) Listen to this Section


$1.37
-0.0300 ( -2.14% ) 88.3K

Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).

Market Data


Open


$1.37

Previous close


$1.40

Volume


88.3K

Market cap


$7.76M

Day range


$1.34 - $1.47

52 week range


$0.97 - $3.21

Insider Ownership Transactions

Total Amount Purchased: -90,983.00 | $ -124,646.71

Date Type Amount Purchased Purchaser
2024-05-10 Buy 12255.00 Petersen Greg
2024-05-10 Buy 9804.00 Clowes Howard
2024-05-10 Buy 4167.00 Lenk Robert P
2024-05-10 Buy 4902.00 Hawkins Richard J
2024-05-10 Buy 4902.00 Sims Andrew John Hugh MacIntyre
2024-05-10 Buy 12255.00 HEDRICK MARC H
2024-02-26 Sale -18933.00 Sims Andrew John Hugh MacIntyre
2024-02-26 Sale -24073.00 LaFrance Norman D.
2024-02-26 Sale -2250.00 van Es-Johansson An
2024-02-26 Sale -94012.00 HEDRICK MARC H

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 13 Aug 15, 2024
8-k 8K-related 12 Aug 14, 2024
10-q Quarterly Reports 61 Aug 14, 2024
ars Annual reports 1 Jul 10, 2024
def Proxies and info statements 13 Jul 10, 2024
8-k 8K-related 11 Jun 07, 2024
8-k 8K-related 20 Jun 04, 2024
8-k 8K-related 11 May 20, 2024
8-k 8K-related 12 May 15, 2024
10-q Quarterly Reports 49 May 15, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.